Health Condition 1: J459- Other and unspecified asthma
Conditions
Interventions
None listed
Sponsors
Dr Anisha Susan Sojan
Eligibility
Inclusion criteria
Inclusion criteria: a) Children aged 6 years to 18 years admitted in the Department of Pediatrics and diagnosed to have Persistent asthma (as per GINA guidelines) and started on inhaled corticosteroids will be enrolled. b) The compliance to ICS will be checked at follow up. (Compliance will be considered good if the child takes the inhaler as prescribed on at least 20/30 days in a month, and the inhaler meter reading will also be checked.)
Exclusion criteria
Exclusion criteria: a) Children having co-existing cardiac disease/Diabetes Mellitus/Hypothyroidism. b) Children who are already on systemic corticosteroids/previously used inhalational corticosteroids c) Children whose parents refuse to participate in the study. d) Children younger than 6 years
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study the HbA1c levels of children aged 6-18 years using ICS for asthma at baseline and after 6months of ICS useTimepoint: From obtaining IEC clearance to Aug 2021 Case Enrollment : Dec 2019 to Feb 2021 Follow up period : June 2020 to Aug 2021 | — |
Secondary
| Measure | Time frame |
|---|---|
| To study the correlation between doses of Inhaled Corticosteroids (Low dose, Medium dose, High Dose according to GINA guidelines) and HbA1c level To study Clinical profile of children 6-18 years with Persistent Asthma Timepoint: From obtaining IEC clearance to Aug 2021 Case Enrollment : Dec 2019 to Feb 2021 Follow up period : June 2020 to Aug 2021 | — |
Countries
India
Contacts
Public ContactANISHA SUSAN SOJAN
KASTURBA MEDICAL COLLEGE, MANIPAL
Outcome results
None listed